Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
Mason
P D
PD
Oxford Renal Unit.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009402:Nephrosis, Lipoid / Q000150:complications / Q000188:drug therapy*; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology; D013256:Steroids
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000893:Anti-Inflammatory Agents; D013256:Steroids; D003520:Cyclophosphamide